SCHEMBL2591865

SCHEMBL2591865

Cc1nc2ccccn2c1P(=O)(c1ccccc1)c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 5/20 1.00
HSD17B10 Q99714 3/20 0.58
HPGD P15428 1/20 0.58
KMT2A Q03164 4/20 0.54
ALDH1A1 P00352 3/20 0.54
MEN1 O00255 1/20 0.54
KDM4E B2RXH2 3/20 0.53
LMNA P02545 3/20 0.51
CRHBP P24387 1/20 0.51
CRHR2 Q13324 1/20 0.51
GAA P10253 1/20 0.48
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
GLA P06280 1/20 0.46
TP53 P04637 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2582202 0.83 NPSR1 (1.00) NPSR1HSD17B10HPGDKMT2AALDH1A1
SCHEMBL18901345 0.71 KMT2A (0.54) NPSR1HSD17B10HPGDKMT2AALDH1A1
SCHEMBL266148 0.70 KMT2A (0.58) NPSR1HSD17B10HPGDKMT2AALDH1A1
SCHEMBL14039272 0.69 KMT2A (0.57) NPSR1HSD17B10KMT2AALDH1A1KDM4E
SCHEMBL954146 0.69 KMT2A (0.76) NPSR1HSD17B10KMT2AALDH1A1MEN1
SCHEMBL15004608 0.69 KMT2A (0.61) NPSR1HSD17B10HPGDKMT2AALDH1A1
SCHEMBL11357473 0.68 KMT2A (0.56) NPSR1HSD17B10HPGDKMT2AALDH1A1
SCHEMBL9611707 0.68 ALDH1A1 (0.56) NPSR1HSD17B10HPGDKMT2AALDH1A1
SCHEMBL2590640 0.68 NPSR1 (0.69) NPSR1HPGDALDH1A1KDM4EGAA
SCHEMBL792006 0.67 KMT2A (0.59) NPSR1HSD17B10HPGDKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011137220-A1 SMALL MOLECULE NEUROPEPTIDE S ANTAGONISTS FOR THE TREATMENT OF ADDICTIVE DISORDERS, MOOD, ANXIETY AND SLEEP DISORDERS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-11-03 WO disclosed
WO-2011137220-A1 SMALL MOLECULE NEUROPEPTIDE S ANTAGONISTS FOR THE TREATMENT OF ADDICTIVE DISORDERS, MOOD, ANXIETY AND SLEEP DISORDERS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-11-03 WO disclosed